ISELIS GARCIA: Open Payments
NPI 1659777480 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,778 in 143 payments from 18 companies in 2025. Trend: 2023 $2,208 · 2024 $2,203 · 2025 $2,778
Food & beverage: $2,778
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $695 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $395 |
| Madrigal Pharmaceuticals | 14 | $330 |
| Janssen Biotech, Inc. | 20 | $329 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $179 |
| QOL Medical, LLC | 6 | $142 |
| Regeneron Healthcare Solutions, Inc. | 6 | $135 |
| GENZYME CORPORATION | 5 | $115 |
| Lilly USA, LLC | 5 | $102 |
| Gilead Sciences, Inc. | 4 | $83 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, ENTYVIO, DUPIXENT, XIFAXAN, Sucraid, LINZESS.
Industry payments across FL — which companies pay providers there.
